Minimal residual disease diagnostics in patients with multiple myeloma

被引：0
|
作者：
Huhn, S. [1 ]
机构：
[1] Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V484
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [21] Drug resistance and minimal residual disease in multiple myeloma
    Gozzetti, Alessandro
    Ciofini, Sara
    Sicuranza, Anna
    Pacelli, Paola
    Raspadori, Donatella
    Cencini, Emanuele
    Tocci, Dania
    Bocchia, Monica
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 171 - 183
  • [22] Recommendations for quantitation of minimal residual disease in multiple myeloma
    Rasmussen, T
    Johnsen, HE
    BONE MARROW TRANSPLANTATION, 2002, 29 : S128 - S128
  • [23] Targeting minimal residual disease in myeloma patients
    Kroeger, N.
    ONKOLOGIE, 2010, 33 : 10 - 11
  • [24] Molecular Monitoring of Minimal Residual Disease in the Peripheral Blood of Patients with Multiple Myeloma
    Korthals, Mark
    Sehnke, Nina
    Kronenwett, Ralf
    Schroeder, Thomas
    Strapatsas, Tobias
    Kobbe, Guido
    Haas, Rainer
    Fenk, Roland
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) : 1109 - 1115
  • [25] Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients
    Paiva, Bruno
    Cedena, Maria-Teresa
    Puig, Noemi
    Arana, Paula
    Vidriales, Maria-Belen
    Cordon, Lourdes
    Flores-Montero, Juan
    Gutierrez, Norma C.
    Martin-Ramos, Maria-Luisa
    Martinez-Lopez, Joaquin
    Ocio, Enrique M.
    Hernandez, Miguel T.
    Teruel, Ana-Isabel
    Rosinol, Laura
    Echeveste, Maria-Asuncion
    Martinez, Rafael
    Gironella, Mercedes
    Oriol, Albert
    Cabrera, Carmen
    Martin, Jesus
    Bargay, Joan
    Encinas, Cristina
    Gonzalez, Yolanda
    Van Dongen, Jacques J. M.
    Orfao, Alberto
    Blade, Joan
    Mateos, Maria-Victoria
    Jose Lahuerta, Juan
    San Miguel, Jesus F.
    BLOOD, 2016, 127 (25) : 3165 - 3174
  • [26] Functional and psychological impact of minimal residual disease assessment on patients with multiple myeloma
    Correia, Nuno
    Dowling, Emma
    Popat, Rakesh
    Rabin, Neil
    Kyriakou, Chara
    Sive, Jonathan
    Yong, Kwee
    Wechalekar, Ashutosh
    BRITISH JOURNAL OF HAEMATOLOGY, 2023,
  • [27] Determination of Minimal Residual Disease in Multiple Myeloma: Does It Matter?
    Kothari, Shalin
    Hillengass, Jens
    McCarthy, Philip L.
    Holstein, Sarah A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (01) : 39 - 46
  • [28] Multiple myeloma patient perceptions of minimal residual disease testing
    Hydren, Jay
    Martinez, Jorge Arturo Hurtado
    Quiroz, Felipe Flores
    Perez, Patricia Alejandra Flores
    Espinoza, Andrea Isabel Robles
    Vicencio, Andrea Jimena Cuevas
    Flores, Marilu Najera
    Hernandez, Eduardo Franco
    Aldana, Ana Sahagun Sanchez
    Sweeney, Nathan
    Ahlstrom, Jennifer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S74 - S74
  • [29] Minimal residual disease in multiple myeloma: Benefits of flow cytometry
    Galtseva, I. V.
    Davydova, Y. O.
    Kapranov, N. M.
    Julhakyan, H. L.
    Mendeleeva, L. P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (01) : 12 - 20
  • [30] Minimal residual disease in multiple myeloma: bringing the bench to the bedside
    Mailankody, Sham
    Korde, Neha
    Lesokhin, Alexander M.
    Lendvai, Nikoletta
    Hassoun, Hani
    Stetler-Stevenson, Maryalice
    Landgren, Ola
    NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (05) : 286 - U139
12345